Related Experiment Video
Updated: Sep 18, 2025
14:18
Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
1.9K
Treating IgA Nephropathy: Looking at the Future Without Forgetting the Past.
1Fondazione Ricerca Molinette, 10129 Turin, Italy.
Journal of Clinical Medicine
|June 26, 2025
Summary
IgA nephropathy (IgAN) treatment is evolving. While corticosteroids show benefits, newer approaches like targeted budesonide and novel drugs offer comparable efficacy with improved safety for kidney protection.
Area of Science:
- Nephrology
- Immunology
- Pharmacology
Background:
- IgA nephropathy (IgAN) is an inflammatory kidney disease driven by galactose-deficient IgA1 (Gd-IgA1) and subsequent immune complex deposition.
- Proteinuria is a key marker for IgAN progression, necessitating effective kidney protection strategies.
Purpose of the Study:
- To review the current treatment landscape for IgA nephropathy (IgAN), focusing on corticosteroids and emerging therapies.
- To evaluate the efficacy and safety of different treatment modalities in managing IgAN and preventing kidney function decline.
Main Methods:
- Review of clinical trials and guidelines concerning IgA nephropathy (IgAN) treatments.
- Analysis of systemic corticosteroids, targeted budesonide, and novel therapeutic agents targeting IgAN pathogenesis.
Main Results:
- Systemic corticosteroids offer kidney protection but carry significant adverse event risks, leading to guideline revisions.
- Reduced-dose methylprednisolone with prophylaxis and targeted budesonide show comparable efficacy to full-dose corticosteroids with improved safety profiles.
- Emerging therapies targeting B cells, complement activation, and the endothelin system demonstrate promising results for IgAN treatment.
Conclusions:
- The management of IgA nephropathy (IgAN) is shifting towards safer and more targeted therapeutic strategies.
- Novel drug development holds significant promise for improving long-term kidney outcomes in IgAN patients.
Related Concept Videos
01:28Chronic Kidney Disease III: Interprofessional Care
84
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
84
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
64
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
64
01:24Nephrotic Syndrome III : Nursing Management
49
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
49
01:26Nephrotic Syndrome II : Assessment and Medical Management
25
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
25
01:20Acute Kidney Injury V: Interprofessional Care
51
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
51
01:18Chronic Kidney Disease IV: Nursing Management
61
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
61